An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients

Inclusion Criteria: * Chinese. * Diagnosis of bacterial conjunctivitis based on clinical observation. * Understand and sign the approved informed consent. Legally authorized representative can provide informed consent for patients less than 18 years old and/or incapable of understanding the informed consent. * Willing to complete all required study procedures and visits. * Other protocol-defined inclusion criteria may apply. Exclusion Criteria: * Women who are pregnant, lactating, or planning a pregnancy. * Only 1 sighted eye or vision not correctable to 0.6 logMAR or better in either eye. * Planned contact lens wear during the course of the study. * Signs and symptoms of bacterial conjunctivitis for longer than 4 days prior to Screening (Day 1). * Suspected fungal, viral, or Acanthamoeba infection. * Any systemic or ocular disease or disorder, complicating factor or structural abnormality that would negatively affect the conduct or outcome of the study. * History of recent surgery. * Presence of concomitant systemic viral infection. * Other protocol-defined exclusion criteria may apply.